Immutep Limited (YP1A) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.086x

Based on the latest financial reports, Immutep Limited (YP1A) has a cash flow conversion efficiency ratio of -0.086x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.72 Million ≈ $-13.70 Million USD) by net assets (€136.47 Million ≈ $159.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Immutep Limited - Cash Flow Conversion Efficiency Trend (2017–2023)

This chart illustrates how Immutep Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Immutep Limited debt and liabilities for a breakdown of total debt and financial obligations.

Immutep Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immutep Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Microcosm Technology Co Ltd TWO:3354	-0.025x
Ginar Technology Co Ltd TWO:6151	0.010x
ENERGY&MACHINERY KOREA Co.Ltd KQ:095190	-0.094x
Ahn-Gook Pharmaceutical Co. Ltd KQ:001540	0.086x
Pesona Metro Holdings Bhd KLSE:8311	0.130x
S Chand And Company Limited NSE:SCHAND	-0.061x
Lesico Ltd TA:LSCO	0.226x
AFC Gamma Inc NASDAQ:AFCG	-0.003x

Annual Cash Flow Conversion Efficiency for Immutep Limited (2017–2023)

The table below shows the annual cash flow conversion efficiency of Immutep Limited from 2017 to 2023. For the full company profile with market capitalisation and key ratios, see Immutep Limited market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	€136.47 Million ≈ $159.55 Million	€-35.36 Million ≈ $-41.33 Million	-0.259x	-17.20%
2022-06-30	€136.76 Million ≈ $159.88 Million	€-30.23 Million ≈ $-35.34 Million	-0.221x	+8.19%
2021-06-30	€73.27 Million ≈ $85.66 Million	€-17.64 Million ≈ $-20.62 Million	-0.241x	+26.04%
2020-06-30	€33.30 Million ≈ $38.93 Million	€-10.84 Million ≈ $-12.67 Million	-0.326x	+48.07%
2019-06-30	€24.39 Million ≈ $28.51 Million	€-15.29 Million ≈ $-17.87 Million	-0.627x	-170.19%
2018-06-30	€33.52 Million ≈ $39.19 Million	€-7.78 Million ≈ $-9.09 Million	-0.232x	+27.64%
2017-06-30	€26.53 Million ≈ $31.02 Million	€-8.51 Million ≈ $-9.95 Million	-0.321x	--

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$61.95 Million

€52.99 Million EUR

Market Cap Rank

#21038 Global

#1892 in Germany

Share Price

€0.36

Change (1 day)

-16.28%

52-Week Range

€0.24 - €2.64

All Time High

€4.52